STTPF Dividend: SCHOTT Pharma AG & Co KgaA Yield Insights

Q: What is SCHOTT Pharma AG & Co KgaA's current dividend paid and annual dividend?

The current dividend paid by SCHOTT Pharma AG & Co KgaA is $0.16. The annual dividend for SCHOTT Pharma AG & Co KgaA is $0.16

Q: What is SCHOTT Pharma AG & Co KgaA's dividend payout ratio?

The dividend payout ratio for SCHOTT Pharma AG & Co KgaA is 0.00%

Q: What is the ex-dividend date for STTPF?

The ex-dividend date for SCHOTT Pharma AG & Co KgaA is Feb 5, 2025.

Q: How often does SCHOTT Pharma AG & Co KgaA pay dividends?

Quarterly. The last time SCHOTT Pharma AG & Co KgaA paid dividend was on Feb 7, 2025

Home

Stock

STTPF

STTPF Dividends

SCHOTT Pharma AG & Co KgaA

0%

$0

At close: Jan 28, 16:00:00 GMT-5

0%

$0

Pre-market: Jan 29, 05:23:44 GMT-5

Overview Forecast Earnings Dividends Financials

SCHOTT Pharma AG & Co KgaA Dividend Information



SCHOTT Pharma AG & Co KgaA has an annual dividend of 0.16 per share, with a yield of 0.00%. The dividend is paid annually and the last ex-dividend date was Feb 5, 2025.

Dividend Yield

Annual Dividend

Ex-Dividend Date

0.00%

$0.16

Feb 5, 2025

Payout Frequency

Payout Ratio

Annually

0.00%

Dividend History

Ex-Dividend Date	Cash Amount	Record Date	Pay Date
Feb 5, 2025	$0.16	Feb 6, 2025	Feb 7, 2025
Mar 15, 2024	$0.15	Mar 18, 2024	Mar 19, 2024

Dividend Charts

STTPF Dividends

STTPF Dividend Growth (YoY)

Follow-Up Questions

What is SCHOTT Pharma AG & Co KgaA's current dividend paid and annual dividend?



What is SCHOTT Pharma AG & Co KgaA's dividend payout ratio?



What is the ex-dividend date for STTPF?



How often does SCHOTT Pharma AG & Co KgaA pay dividends?



Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

EPS (TTM)

Dividend yield

Market Cap

What is STTPF?

SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.



Features

AI Copilot for Stock & Crypto

Trading Strategies

Megabrain Investors Picks

Trading Mindshare